Jul 6, 2026 08:31AM
Jun 8, 2026 06:58AM
Jun 4, 2026 08:32AM
May 21, 2026 08:32AM
May 19, 2026 03:11PM
May 11, 2026 08:31AM
May 5, 2026 08:31AM Fate Therapeutics selected for FDA manufacturing pilot program
May 4, 2026 07:33AM
Mar 24, 2026 03:04PM
Feb 26, 2026 03:24PM
Dec 21, 2025 04:00AM
Nov 13, 2025 04:33PM
Nov 4, 2025 09:05AM
Oct 31, 2025 06:12AM H.C. Wainwright Upgrades Fate Therapeutics (FATE) to Buy
Oct 27, 2025 06:53AM
Oct 27, 2025 12:29AM
Sep 3, 2025 06:20AM
Aug 13, 2025 05:24AM
Aug 12, 2025 05:31PM
Jul 2, 2025 06:39AM
Jun 12, 2025 07:25AM Needham Reiterates Hold Rating on Fate Therapeutics (FATE)
Jun 11, 2025 01:00PM
Jun 11, 2025 09:02AM
May 30, 2025 04:30PM
May 28, 2025 05:55PM
May 14, 2025 04:30AM
May 13, 2025 06:12PM
Apr 14, 2025 08:01AM Fate Therapeutics (FATE) Receives RMAT Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus
Mar 6, 2025 09:54AM
Mar 6, 2025 05:19AM
Mar 5, 2025 04:53PM
Jan 2, 2025 04:00PM
Dec 9, 2024 04:02PM
Nov 29, 2024 01:05PM
Nov 18, 2024 03:49PM BofA Securities Upgrades Fate Therapeutics (FATE) to Neutral, 'Following initial autoimmune clinical data presented at ACR Convergence'
Nov 18, 2024 02:11PM
Nov 18, 2024 01:31PM
Nov 18, 2024 11:22AM
Nov 18, 2024 08:05AM
Nov 13, 2024 08:53AM
Nov 12, 2024 09:22PM
Aug 14, 2024 02:05PM TD Cowen Reiterates Hold Rating on Fate Therapeutics (FATE)
Aug 14, 2024 10:08AM
Aug 14, 2024 08:37AM
Aug 14, 2024 08:23AM
Aug 13, 2024 05:07PM
Aug 13, 2024 05:07PM
Jul 31, 2024 08:03AM
Jun 17, 2024 03:50AM Piper Sandler Upgrades Fate Therapeutics (FATE) to Overweight
Feb 9, 2022 02:37PM

426,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All